These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4978130)

  • 21. [The relationship between the formation of tetanus antitoxin in humans, the dose of antigen and the number of immunizations. I. The reactogenicity and effectiveness of purified sorbed anatoxin in the primary immunization].
    Kashintseva NS; Dzhavrova IK; Kireev IE; Davydov IK
    Zh Mikrobiol Epidemiol Immunobiol; 1967 May; 44(5):84-8. PubMed ID: 5617976
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anti-tetanus serum or anatoxin?].
    Grosbuis S
    Rev Prat; 1974 Nov; 24(51):4505-6, 4509-11. PubMed ID: 4475480
    [No Abstract]   [Full Text] [Related]  

  • 23. The antitoxic activity and gamma globulin distribution in fractionated diphtheria and tetanus antitoxin of equine origin.
    LEVINE L
    Br J Exp Pathol; 1952 Apr; 33(2):190-5. PubMed ID: 14935082
    [No Abstract]   [Full Text] [Related]  

  • 24. [Development of autoimmune reactions in horses serving to produce antitetanus serum].
    Georgadze IA; Nozadze ZM
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):86-9. PubMed ID: 3705815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dynamics of the plasmacyte reaction following administration of tetanus anatoxin by the aerosol and subcutaneous methods].
    Miroshnichenko IV
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Dec; 46(12):89-93. PubMed ID: 5393538
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on tetanus antitoxin. I. Isolation of two neutralizing antibodies from tetanus antitoxin.
    Cohen H; Nagel J; van der Veer M; Peetoom F
    J Immunol; 1970 Jun; 104(6):1417-23. PubMed ID: 4192575
    [No Abstract]   [Full Text] [Related]  

  • 27. [Radio-immunoelectrophoretic study of the development of serum antibodies after antitetanus vaccination. Use in the control of a new method of vaccination].
    Masseyeff R; Seck I; Rey M; Triau R
    Bull Soc Med Afr Noire Lang Fr; 1967; 12(2):240-7. PubMed ID: 5606057
    [No Abstract]   [Full Text] [Related]  

  • 28. The isolation and properties of the proteins associated with tetanus antitoxic activity in equine plasma.
    SMITH EL; GERLOUGH TD
    J Biol Chem; 1947 Mar; 167(3):679-87. PubMed ID: 20287898
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experience with a single intranasal revaccination with diphtheria-tetanus anatoxin].
    Alatyrtseva IE; Maianskiĭ AN
    Zh Mikrobiol Epidemiol Immunobiol; 1967 May; 44(5):81-4. PubMed ID: 5617975
    [No Abstract]   [Full Text] [Related]  

  • 30. The quantitative flocculation reaction of equine tetanus antitoxin.
    LEVINE L
    Br J Exp Pathol; 1959 Aug; 40(4):343-57. PubMed ID: 14416263
    [No Abstract]   [Full Text] [Related]  

  • 31. Quantification of tetanus antitoxin in human sera. II. Comparison of counter-immunoelectrophoresis and passive haemagglutination with toxin neutralization in mice.
    Winsnes R; Christiansen G
    Acta Pathol Microbiol Scand B; 1979 Jun; 87B(3):197-200. PubMed ID: 474133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of tetanus and diphtheria antitoxin content in dried samples of capillary blood: a convenient method applied to infants.
    Schou C; Simonsen O; Heron I
    Scand J Infect Dis; 1987; 19(4):445-51. PubMed ID: 3672050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical tetanus in a completely immunized 14-year-old boy.
    König K; Ringe H; Dorner BG; Diers A; Uhlenberg B; Müller D; Varnholt V; Gaedicke G
    Pediatrics; 2007 Nov; 120(5):e1355-8. PubMed ID: 17974728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effectiveness of active-passive prevention of tetanus in children].
    Matveev KI; Dzhavrova IK; Petrov PN; Kasparova EM; Kashintseva NS
    Zh Mikrobiol Epidemiol Immunobiol; 1969 May; 46(5):72-7. PubMed ID: 5816419
    [No Abstract]   [Full Text] [Related]  

  • 35. ELISA for the routine determination of antitoxic immunity to tetanus.
    Simonsen O; Bentzon MW; Heron I
    J Biol Stand; 1986 Jul; 14(3):231-9. PubMed ID: 3759998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoglobulins in hyperimmune horse serum.
    Sardesai SK; Rao SS
    Indian J Biochem; 1968 Jun; 5(2):46-9. PubMed ID: 4183032
    [No Abstract]   [Full Text] [Related]  

  • 37. Transfer rate of transplacental immunity to tetanus from non-immunized and immunized mothers.
    Sangpetchsong V; Vichaikummart S; Vichitnant A; Podhipak A
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):275-80. PubMed ID: 6523168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The persistence in the human circulation of horse and human tetanus antitoxins.
    SMOLENS J; VOGT AB; CRAWFORD MN; STOKES J
    J Pediatr; 1961 Dec; 59():899-902. PubMed ID: 13914498
    [No Abstract]   [Full Text] [Related]  

  • 39. [Isoelectric focusing and immunochemical analysis of the proteins of the anti-tetanus serum "Diaferm-3"].
    Kulygina RM; Lutsenko VK; Sakharova OP
    Biull Eksp Biol Med; 1974 Oct; 78(10):41-5. PubMed ID: 4142591
    [No Abstract]   [Full Text] [Related]  

  • 40. [A gel filtration study of the fractional composition of tetanus antitoxic sera].
    Runova VF; Kargina TM; Gavrilenkova VIu; Selezneva VP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jun; (6):46-8. PubMed ID: 1887709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.